8 April 2024 - Australians with high cholesterol, chronic kidney disease and ovarian cancer now have access to cheaper medicines under the PBS.
Inclisiran (Leqvio) will be listed for the first time for the treatment of hereditary (familial) high levels of cholesterol and also non-hereditary (non-familial) high cholesterol with atherosclerotic (narrowing blood vessels) cardiovascular disease.